Patents
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
07/2004
07/07/2004CN1156446C Indenoindolone compounds, their preparation and medicinal compositions containing them
07/06/2004US6759554 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
07/06/2004US6759548 Dialkyl-halogenophenyl-substituted ketoenols
07/06/2004US6759534 Reacting benzofuran derivative with organolithium compound in presence of sulfur source; reacting with dichloropyridazine derivative, reacting with alkaline alkoxide in alkanol; reacting with mineral acid, oxidation
07/06/2004US6759428 Indole nitriles
07/06/2004US6759424 Imidazolidine derivatives, their preparation, their use, and pharmaceutical preparations comprising them
07/06/2004US6759415 Affinity with subtypes of somatostatin receptors
07/06/2004US6759414 Aromatic amides
07/06/2004US6759411 Heterocyclic piperidines as modulators of chemokine receptor activity
07/06/2004US6759409 Inhibitors of papilloma virus
07/06/2004US6759101 Useful in ferroelectric liquid crystal compositions; use to lower melting point or lower freezing point, of liquid crystal compositions
07/01/2004WO2004055015A1 Aminocyanopyridine inhibitors of mitogen activated protein kinase-activated protein kinase-2
07/01/2004WO2004055010A2 Cyclopropyl compounds as ccr5 antagonists
07/01/2004WO2004055004A1 Carboxylic acid, phosphate or phosphonate substituted quinazolin-4-ylamine analogues as capsaicin receptor modulators
07/01/2004WO2004055003A1 2-substituted quinazolin-4-ylamine analogues as capsaicin receptor modulators
07/01/2004WO2004054987A1 Cathepsin cysteine protease inhibitors and their use
07/01/2004WO2004054977A1 Nicotinamide-based kinase inhibitors
07/01/2004WO2004054972A1 N-(indolethyl-)cacloamine compounds
07/01/2004WO2004054624A1 Cytotoxins and diagnostic imaging agents comprising hsp90 ligands
07/01/2004WO2004054584A1 Novel quinoxalinone derivatives as bradykinin b1 antagonists
07/01/2004WO2004054498A2 Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof
07/01/2004WO2004037170A3 Process for making spirolactone compounds
07/01/2004WO2004031145A3 Lactam-containing diaminoalkyl, beta-aminoacids, alpha-aminoacids and derivatives thereof as factor xa inhibitors
07/01/2004WO2004026306A3 Pyrazole derivatives as transforming growth factor (tgf) inhibitors
07/01/2004WO2004017911A3 Protease inhibitors
07/01/2004WO2004012656A3 Thiophene and furan derivatives as prostaglandin agonists and use thereof
07/01/2004WO2003099844A3 Protease inhibitors
07/01/2004WO2003093297A3 Protein kinase modulators and methods of use
07/01/2004WO2003080577A3 Amidoacetonitrile compounds
07/01/2004US20040127733 adrenergic blocking agents; for treatment of diabetes/obesity
07/01/2004US20040127723 Process for preparing heterocyclic indene analogs
07/01/2004US20040127721 Process for the synthesis of bis-aryl diamidoxime compounds
07/01/2004US20040127713 relaxing action of tracheal smooth muscles, inhibition of airway hypersensitivity and inhibition of infiltration of inflammatory cells into the airway; useful as antiasthmatic drugs
07/01/2004US20040127712 Aminoalkyl-3, 4-dihydroquinoline derivatives as no-synthase inhibitors
07/01/2004US20040127708 antiviral activities; aids treatment
07/01/2004US20040127707 Novel phthalazinones
07/01/2004US20040127689 activated haptens useful for generating immunogens to HIV protease inhibitors
07/01/2004US20040127549 Cyclic 2-carbonylaminoketones as inhibitors of cruzipain and other cysteine proteases
07/01/2004US20040127543 Antidepressant cycloalkylamine derivatives of 2,3-dihydro-1,4-benzodioxan
07/01/2004US20040127536 Indazole Derivatives
07/01/2004US20040127528 Metalloproteinase inhibitors
07/01/2004US20040127527 Large conductance calcium-activated k channel opener
07/01/2004US20040127518 For therapy of anxiety or pain, and other neurological, sleep, or psychological disorders, for inducing sleep, for treating glaucoma, and controlling appetite or appetive disorders
07/01/2004US20040127517 For therapy of treat atherosclerosis, autoimmune diseases, multiple sclerosis), asthma, rheumatoid arthritis, fibrotic diseases, idiopathic pulmonary fibrosis, cystic fibrosis, glumerulonephritis, rheumatoid spondylitis, osteoarthritis, gout
07/01/2004US20040127513 For prophylaxis and therapy of chronic or acute inflammatory or autoimmune diseases, those associated with aberrant lymphocyte or monocyte accumulation such as arthritis, asthma, atherosclerosis, diabetic nephropathy, inflammatory bowel disease
07/01/2004US20040127510 Arylindenopyridines and arylindenopyrimidines and related therapeutic and prophylactic methods
07/01/2004US20040127507 Imidazolidine compounds
07/01/2004US20040127502 Use of pyrimidine compound galanin receptor subtype 3 (GAL3) antagonists, which may be classified as neutral antagonists, inverse agonists or allosteric modulators, to treat depressive disorders and/or anxiety
07/01/2004US20040127494 Sulfur compounds such as (2R)-2-[N-(4-Chlorobenzenesulfonyl)-N-(4-methoxybenzyl)amino]-4-methylpentanoic acid amide, used for prophylaxis of neurodegenarative disorders such as Alzheimer's Disease and Down's Syndrome
07/01/2004US20040127424 Inhibitors of cruzipain and other cysteine proteases
07/01/2004DE10261091A1 Gesättigte und ungesättigte Heteroarylcycloalkylmethyl-Amine Saturated and unsaturated amines Heteroarylcycloalkylmethyl
07/01/2004DE10260730A1 Neue substituierte stickstoffhaltige Heterobicyclen, deren Herstellung und deren Verwendung als Arzneimittel New substituted nitrogen containing heterobicycles, their preparation and their use as medicaments
07/01/2004DE10259933A1 Substituierte 4-Aryl-Pyridine 4-aryl-substituted pyridines
07/01/2004DE10259244A1 N-(Indolethyl-)cycloamin-Verbindungen N- (Indolethyl-) cyclo amine compounds
07/01/2004DE10257785A1 Isophthalsäurederivate Isophthalic acid derivatives
07/01/2004CA2549463A1 Cytotoxins and diagnostic imaging agents comprising hsp90 ligands
07/01/2004CA2510169A1 N-(indolethyl-)cycloamine compounds
07/01/2004CA2509244A1 Aminocyanopyridine inhibitors of mitogen activated protein kinase-activated protein kinase-2
07/01/2004CA2509239A1 Carboxylic acid, phosphate or phosphonate substituted quinazolin-4-ylamine analogues as capsaicin receptor modulators
07/01/2004CA2509233A1 2-substituted quinazolin-4-ylamine analogues as capsaicin receptor modulators
07/01/2004CA2507425A1 Novel quinoxalinone derivatives as bradykinin b1 antagonists
06/2004
06/30/2004EP1433781A1 Pyrrolidine carboxylic acid derivatives
06/30/2004EP1433479A1 Appetite-stimulating agents and remedies for anorexia
06/30/2004EP1432706A2 3-pyridyl or 4-isoquinolinyl thiazoles as c17,20 lyase inhibitors
06/30/2004EP1432704A1 Synthesis of key azole-antifungal intermediates
06/30/2004EP1432703A1 Heterocycle-carboxamide derivatives as raf kinase inhibitors
06/30/2004EP1432702A1 Nitrogen-containing heterocyclic compounds and their use as raf inhibitors
06/30/2004EP1432701A1 Heterocyclic compounds for use in the treatment of disorders of the urinary tract
06/30/2004EP1432699A1 Pyridylfurans and pyrroles as raf kinase inhibitors
06/30/2004EP1432698A2 Substituted 3-pyridyl indoles and indazoles as c17,20 lyase inhibitors
06/30/2004EP1432697A1 Pyridylfurans and pyrroles as raf kinase inhibitors
06/30/2004EP1432696A1 Chroman derivatives as 5-hydroxytryptamine-6 ligands
06/30/2004EP1432693A2 Mch receptor antagonists
06/30/2004EP1432691A1 Imidazole-4-carboxamide derivatives, preparation and use thereof for treatment of obesity
06/30/2004EP1432690A2 Imidazole, thiazole and oxazole derivatives and their use for the manufacture of a medicament for the treatment and/or prevention of pollakiuria or urinary incontinence
06/30/2004EP1432689A1 Pyrazole derivatives useful in the treatment of hyper-proliferative disorders
06/30/2004EP1432421A1 Quinoline derivatives as neuropeptide y antagonists
06/30/2004EP1432417A2 Substituted benzimidazole compounds and their use for the treatment of cancer
06/30/2004EP1432416A1 Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them
06/30/2004EP1432415A1 Substituted 2,5-diamidoindoles as ece inhibitors for the treatment of cardiovascular diseases
06/30/2004EP1432313A1 N-thio-nicotinamide derivatives and related compounds for use as pesticides
06/30/2004EP1149072B1 Sulfonamide hydroxamates
06/30/2004EP1037880B1 Retinoic acid mimetic anilides
06/30/2004EP0958289B1 Amino acid ester containing azole antifungals
06/30/2004EP0746555B1 High temperature epoxy resins
06/30/2004CN1509286A Metalloproteinase inhibitors
06/30/2004CN1509282A 4-(phenyl-piperdin-4-ylidene-methyl)benzamide derivatives and theive use for treating pain, anxiety or gastrointestinal disorders
06/30/2004CN1509278A N-phenyl-arylsulfonamide compound, drug comprising the compound as active ingredient, intermediate for the compound
06/30/2004CN1509276A Metalloproteinase inhibitors
06/30/2004CN1509275A Metalloproteinase inhibitors
06/30/2004CN1509274A Metallo proteinase inhibitors
06/30/2004CN1509273A Metalloproteinase inhibitors
06/30/2004CN1509272A Metalloproteinase inhibitors
06/30/2004CN1509271A 4-(phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for treatment of pain anxiety or gastrointestinal disorders
06/30/2004CN1508135A 2-(1H-1,2,4,-triazole-1-radical)-5-furan methylene imidazolidinone derivatives and bactericidal activity
06/30/2004CN1508129A Method for synthesizing pyrrole amides
06/30/2004CN1155597C Benzodioxan, benzofuran or benzopyranl derivatives having fundic relaxation properties
06/30/2004CN1155596C New phenylpiperazines
06/30/2004CN1155590C Chromone compounds with antineoplastic activity and its open-loop products and preparing process
06/30/2004CN1155589C Compounds and methods for modulation of estroglen receptors